Northwestern University Medical Center

Chicago, Illinois 60654

0 studies enrolling now · 27 studies all time

What they study most

Acute Myeloid Leukemia (AML), Breast Cancer, Breast Reconstruction, Cardio-pulmonary Bypass, Cardiovascular Diseases, Coronary Artery Bypass Graft, Cytomegalovirus (CMV), Cytomegalovirus Infections, Dystrophic Epidermolysis Bullosa, Enteritis, Epidermolysis Bullosa (EB), Epidermolysis Bullosa Simplex

Studies at this site

• A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202) — Running, not enrolling
• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. — Running, not enrolling
• Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission — Completed
• Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer — Stopped early
• Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer — Completed
• A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors — Paused
• Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch Surgery — Stopped early
• Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients — Completed
• Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients — Completed
• Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia — Completed
• Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients — Completed
• Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD) — APPROVED_FOR_MARKETING
• To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB) — Completed
• An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma — APPROVED_FOR_MARKETING
• Reconstruction Outcomes in Immediate Post-mastectomy Breast Reconstruction With ADM — Status unconfirmed
• Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients — Completed
• Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery — Completed
• Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency — Completed
• Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass — Completed
• Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer — Completed
• Safety Study of TAK-700 in Subjects With Prostate Cancer. — Completed
• Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma — Status unconfirmed
• Doxycycline and OA Progression — Completed
• Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure — Completed
• A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer — Completed
• Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies — Stopped early
• Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris — Stopped early